Loading organizations...
§ Private Profile · St Louis, MO, USA
Agriculture technology firm developing sustainable bacterial solutions.
NewLeaf Symbiotics has raised $99.0M across 4 funding rounds.
NewLeaf Symbiotics has raised $99.0M in total across 4 funding rounds.
NewLeaf Symbiotics has raised $99.0M across 4 funding rounds. Most recently, it raised $45.0M Series D in December 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Dec 20, 2023 | $45M Series D | Peter Odemark | Leaps BY Bayer, Otter Capital, S2G Ventures | Announced |
| Sep 7, 2017 | $30M Series C | Ryan Rakestraw, John Pasquesi | Lewis & Clark Ventures, Open Prairie, Pangaea Ventures, RockPort Capital, Sanjeev Krishnan, Yard Ventures | Announced |
| Sep 17, 2014 | $17M Series B | John Pasquesi | Open Prairie, Pangaea Ventures, Daniel Hullah | Announced |
| Jan 10, 2013 | $7M Venture Round | — | Jason Wrone, Keith Gillard, Kevin Kopczynski | Announced |
NewLeaf Symbiotics has raised $99.0M in total across 4 funding rounds.
NewLeaf Symbiotics's investors include Peter Odemark, Leaps by Bayer, Otter Capital, S2G Ventures, Ryan Rakestraw, John Pasquesi, Lewis & Clark Ventures, Open Prairie, Pangaea Ventures, RockPort Capital, Sanjeev Krishnan, Yard Ventures.